StockWatch
·

Bikaji Foods International Ltd Q2 FY27 Results

BIKAJIQ2 FY27 Results
Filing
Result:Steady· Market: Down#Margin squeeze#Cost led#Base effect

Beat/Miss: Beat · Outlook: Optimistic · Guidance: Raised

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue938.5327.8%13.0%
Total Income947.2726.7%12.4%
Expenditure854.3928.2%16.9%
PBT92.8815.0%13.4%
Net Profit68.9615.9%11.2%
OPM12.65%0.83pp2.27pp
NPM7.28%0.68pp1.94pp
EPS2.8217.5%11.3%
View full financials

FMCG core signal (adjusted PAT and EBITDA margin trend) deteriorated — margin compressed to ~12.65% below management's own 13-13.5% guidance and adjusted PAT fell ~16% YoY on cost-led pressure, even though revenue growth of 13% beat the one specific Street marker.

BIKAJI FOODS · Q2 FY27 · THE VERDICT

Growth on track, but the profit gap widens — margin recovery hinges on Nov 15 price hike

Bikaji's Q2 revenue grew 13% YoY, tracking the newly upgraded 17% FY27 guidance, but net profit fell 11% due to unhedged raw material costs. The market is pricing in execution risk the company downplays.

12 Nov 2026 · 6 min read
Revenue

₹938.5 Cr

+13% YoY, on guidance

Net Profit

₹69.0 Cr

-11.2% YoY, compressed

Operating Margin

12.7%

-70 bps vs Q1, -100 bps guidance

Core Snacking

20%+

beat prior 13-15% guidance

The real story: growth on track, profit pays the cost

Bikaji's Q2 looks split-screen. Revenue of ₹938.5 Cr grew 13% YoY, tracking the newly upgraded FY27 guidance of 17%+ — core snacking hit 20%+, western snacks surged 44%, and the premium THF brand is scaling at 60-70%. But net profit slid 11.2% YoY to ₹69 Cr. Operating margin compressed to 12.7% from Q1's ~13.5%. That gap — growth up, profit down — is the quarter.

Management's explanation is transparent: ~1.7% of margin was absorbed by unhedged raw material costs (pulses, edible oil, freight, packing inflation) in Q2-Q3. The company took no price hike in the quarter, opting to absorb the hit and defer pricing to Nov 15 (post-Diwali). Gross margin was stated at 34.4%; the compression cascaded to operating profit. Result: the quarter eats the full cost timing hit. Recovery is priced for Q4, when the 3% price hike takes effect (45 days of benefit in the final quarter) and seasonal strength peaks.

What management claimed vs. what actually holds up

  • Top line growth close to 13% in Q2

  • Core snacking market growth 20%+

  • Western Snacks growth 44%

  • Focus market 35%+ growth (full-year claim)

  • Gross margin in Q2 was 34.4%

  • THF brand ₹160-170 Cr guidance (60-70% growth)

The bulk of guidance held. Core markets beat prior 13-15% guidance at 20%+. Western snacking (on-the-go consumption) is firing. THF retail expansion is on pace for ₹160-170 Cr and 31-33 stores by year-end — tracking 60-70% growth. But focus market growth was overstated. Management claimed 35%+ growth, but Q2 delivered only 7-8% due to a seasonal shift of sweets/gifting from Q2 to Q3 (Diwali moved this year). H2 guidance was revised to 20-23%, acknowledging the mix headwind.

What changed on this call

Bikaji upgraded FY27 revenue guidance from 15%+ to 17%+ (200 bps raise), based on H1 tracking and H2 expected 20%+ growth. EBITDA margin guidance remained 13-13.5% range (flat-to-down from Q1's 13.5%), but H1 came in at 12.6-13%, with Q3 flagged as 'little challenging.' Margin recovery is now pegged to Q4 at 13.5%. THF brand acceleration to 60-70% growth (up from prior 50-60%) is auditable: ₹160-170 Cr target, 31-33 stores by year-end, premium format units. Price hike timing was confirmed: 3% effective Nov 15, post-Diwali, ruling out pre-Diwali hikes.

Operating Profit Margin, %
-3.522.769.0415.3213.5Q1 FY27-1.7Cost hit12.7Q2 FY27
~70 bps margin compression in Q2 from unhedged raw material costs. Price hike deferred to Nov 15; recovery begins Q4.

The bull-bear ledger

  • Core snacking 20%+ growth, beat guidance 13-15%

  • THF brand 60-70% growth, premium format scaling

  • FY27 revenue guidance upgraded to 17%+ (from 15%+)

  • Pricing power demonstrated (3% hike post-Diwali, sector-wide precedent)

  • —

  • Net profit -11.2% YoY despite 13% revenue growth

  • Margin compression Q2-Q3, recovery path dependent on Nov 15 hike sticking

  • Focus market growth overstated (7-8% Q2 vs 35%+ claim); H2 guidance 20-23%

  • Competitive response to 3% price hike uncertain; local players may undercut

  • Stock down 52% from all-time high; FII ownership declining (6.64% → 4.61%)

Risks ranked by severity to a holder

What could derail the recovery narrative

Margin recovery timing (Nov 15 price hike, Q4 delivery)

High

If price hike is delayed, deferred, or faces pushback (competitor undercutting, consumer resistance), Q4 target of 13.5% EBITDA misses. This is the pivot point; a miss resets expectations.

Competitive response to 3% price hike

Medium-High

All players face cost inflation, but unorganized/local competitors may absorb rather than hike. If Bikaji is alone in pricing, market share loss risk in focus and core markets. Management says 'not a choice,' but execution matters.

Focus market structural softness vs. seasonal timing

Medium

Q2 was 7-8% growth; full-year claim is 35%+. Is the gap pure seasonal (sweets shift) or demand loss? H2 guidance 20-23% suggests seasonal, but if Q3-Q4 fails to re-accelerate, 35%+ was overstated.

Q3 margin pressure (sweets peak + no price hike yet)

Medium

Oct is peak sweets season with highest cost pressure (sugar, packing inflation). No price hike until Nov 15. Management expects margin pressure; if it overshoots, Q4 recovery target tightens.

Supply chain fragility (Bhujia manufacturing, Bengal region)

Low

Q1 was hit by Bengal elections; Q2 recovered 20%. But Bhujia is geographic IP (cannot be made elsewhere and branded as Bikaner). Recurrent disruption would constrain growth in a key category.

How the street is positioned

Bikaji trades at ₹487 as of Nov 11, down 51.7% from its all-time high of ₹1007.95. The stock is below its SMA50 (₹515.05) and SMA200 (₹611.79), signaling a bearish intermediate and longer-term trend. RSI at 50.6 is neutral — not oversold. Volume is increasing, which often signals selling pressure rather than accumulation. The stock is 9.1% above its 52-week low (₹446.3), suggesting it has already priced in a significant downside scenario.

Ownership tells an important story. FII stake has declined from 6.64% (Q1 FY26) to 4.61% (Q1 FY27) — a cumulative ~200 bps withdrawal. DII ownership has grown from 13.37% to 17.50% (400 bps gain), and promoter holding is steady at 73.88%. The FII exit — coming as the company upgraded guidance — is a tell: institutional investors are pricing in higher execution risk (margin recovery, competitive vulnerability, secular profitability risk) than the earnings call narrative concedes. This positioning gap (bullish guidance, bearish FII flow) is worth noting.

What to watch next

The Q4 pivot points
  • 1 · Nov 15 price hike adoption & competitive response

    Has the 3% hike stuck across SKUs? Are competitors matching or undercutting? Street feedback from Oct-Nov retail checks will validate whether pricing power is real or fraying.

  • 2 · Q3 October gifting sweets peak & margin trajectory

    October is the peak sweets season. Volume should re-accelerate (management expects 20%+), but cost pressure (sugar, packing) lingers until Nov 15 hike. Does the volume offset the margin hit, or is Q3 earnings a mess?

  • 3 · THF store expansion & unit economics

    31-33 stores by year-end is the target. New store models (2,000 sq ft, 700 sq ft, 800 sq ft) are experimental. Are pre-opening economics positive? Are stores reaching the 60-70% growth pace or is footfall a struggle in macro uncertainty?

  • 4 · Q4 FY27 reported EBITDA & margin recovery

    The decisive number: Does Q4 EBITDA margin hit the 13.5% target? If yes, the Nov 15 hike validation and Q4 seasonal strength narrative holds. If no, structural margin risk resurfaces.

Bikaji is executing growth — core snacking beat guidance, THF is scaling, and guidance upgraded to 17%+. But execution on margin recovery is the real story. The company is banking on a Nov 15 price hike (3%) and Q4 seasonal strength to deliver 13.5% EBITDA margin. That is credible, but the market is pricing it differently: FII have exited, the stock is down 52% from ATH, and volume is increasing. If the price hike sticks and Q4 delivers, the drawdown looks like a buying opportunity. If it doesn't, the market was right to worry.

The number to track: Q4 EBITDA margin. Everything else — competitive position, premium brand durability, medium-term growth — hinges on whether management can defend profitability in a cost-inflation environment. That's the honest read.

Informational and educational content only. Not investment advice.